Docoh
Loading...

SRZN Surrozen

News

From Benzinga Pro
Surrozen Q3 EPS $(0.51) Down From $(0.47) YoY
15 Nov 21
Earnings, News
Surrozen (NASDAQ:SRZN) reported quarterly losses of $(0.51) per share. This is a 8.51 percent decrease over losses of $(0.47) per share from the same period last year.
91 Biggest Movers From Yesterday
12 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers NuZee, Inc. (NASDAQ: NUZE) shares jumped 164.5% to settle at $5.29 on Thursday. NuZee manufacturing partner, Cuvee Coffee, reported an expansion into select Walmart stores nationwide.
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2021
11 Oct 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Upgrades
B of A Securities Initiates Coverage On Surrozen with Buy Rating, Announces Price Target of $11
11 Oct 21
News, Price Target, Initiation, Analyst Ratings
B of A Securities analyst Tazeen Ahmad initiates coverage on Surrozen (NASDAQ:SRZN) with a Buy rating and announces Price Target of $11.
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
8 Oct 21
Biotech, News, Penny Stocks, Guidance, Offerings, Small Cap, FDA, IPOs, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7)
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
7 Oct 21
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6)
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
6 Oct 21
Biotech, News, Penny Stocks, Small Cap, FDA
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5)
Surrozen's Inflammatory Bowel Disease Candidate Shows Encouraging Preclinical Action
6 Oct 21
Biotech, News, Health Care, Movers, Trading Ideas, General
Surrozen Presented Data Supporting Potential Of SZN-1326 At The 2021 United European Gastroenterology Week
5 Oct 21
News, Events
Surrozen, Inc. (NASDAQ:SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, announced today that data from its inflammatory bowel disease (IBD)
50 Biggest Movers From Yesterday
28 Sep 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
12 Health Care Stocks Moving In Friday's Intraday Session
17 Sep 21
Movers
Gainers
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2021
15 Sep 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Guggenheim Initiates Coverage On Surrozen with Buy Rating, Announces Price Target of $20
15 Sep 21
News, Price Target, Initiation, Analyst Ratings
Guggenheim analyst Yatin Suneja initiates coverage on Surrozen (NASDAQ:SRZN) with a Buy rating and announces Price Target of $20.
The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
12 Sep 21
News, Penny Stocks, Small Cap, FDA, Top Stories
Biotech stocks retreated in the holiday-shortened week ending Sept. 10, reversing course from the previous week.
12 Health Care Stocks Moving In Wednesday's After-Market Session
8 Sep 21
Movers
Gainers
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
8 Sep 21
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7)
72 Biggest Movers From Yesterday
8 Sep 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth.
Mid-Afternoon Market Update: Dow Falls Over 200 Points; RenovoRx Shares Spike Higher
7 Sep 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Toward the end of trading Tuesday, the Dow traded down 0.65% to 35,138.64 while the NASDAQ rose 0.13% to 15,383.18. The S&P also fell, dropping 0.27% to 4,522.99.
See Why Surrozen Stock Is Surging On Tuesday
7 Sep 21
Biotech, Long Ideas, News, Health Care, Price Target, Initiation, Small Cap, Analyst Ratings, Movers, Trading Ideas, General
Stifel initiated coverage of Surrozen Inc (NASDAQ: SRZN) with a Buy rating and $19 price target.
12 Health Care Stocks Moving In Tuesday's Intraday Session
7 Sep 21
Intraday Update, Markets, Movers

Press releases

From Benzinga Pro
Surrozen Reports Third Quarter 2021 Financial Results
15 Nov 21
Earnings, Press Releases
Product Candidates SZN-1326 and SZN-043 Advance Toward Initiation of Clinical Studies in 2022 Expanding and Advancing Discovery Stage Pipeline in Multiple Disease Settings SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021
Surrozen to Present at The Piper Sandler 33rd Annual Healthcare Conference
15 Nov 21
News, Health Care, Press Releases
SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Surrozen, Inc., (NASDAQ:SRZN), a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway, today announced
Surrozen to Present at The Stifel 2021 Virtual Healthcare Conference
5 Nov 21
News, Press Releases
SOUTH SAN FRANCISCO, Calif., Nov. 05, 2021 (GLOBE NEWSWIRE) -- Surrozen, Inc., (NASDAQ:SRZN), a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway, today announced
Surrozen Presented Data Supporting Potential of SZN-1326 at the 2021 United European Gastroenterology Week
5 Oct 21
Health Care, Press Releases
SOUTH SAN FRANCISCO, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Surrozen, Inc. (NASDAQ:SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration,
Surrozen Announces Appointment of Liz Nguyen as Vice President and Head of Human Resources
23 Sep 21
News, Management, Press Releases
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Surrozen Inc. (NASDAQ:SRZN), a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway, today announced